Last 5 Days Trading Activity
|Date||Open Price||Close Price||High||Low||Volume|
Last 5 Days Short Activity
|Date||Short Volume||Total Volume||Short Percentage||Short Indicator|
* Short Mode
About Orthometrix, Inc. (OTC: OMRX)
In response to the need of an aging population driven to lead a more active and independent life, Orthometrix, Inc., a Delaware corporation Orthometrix , has developed and/or acquired the rights to, technologies, procedures and devices to assess musculoskeletal conditions, to help restore mobility following orthopedic or neurological trauma sports injury, hip/knee replacement, stroke to maintain or increase musculoskeletal performance and mobility which is inherent to a better quality of life and to help delay the adverse effect on mobility of certain medical conditions like Parkinson s or diabetic neuropathy. Orthometrix manages its worldwide marketing, sales, service and clinical education activities from Naples, Florida and White Plains, NY. R amp D and manufacturing activities are managed by Orthometrix s manufacturing partners in Germany XCT peripheral Quantitative Computed Tomography, Galileo/VibraFlex Whole Body Vibration, Leonardo Force Plate/Mechanography and directly by Orthometrix in France Oscar, Jr. DXA Phantom , and Israel SmartStep Functional BioFeedback Therapy .
- Albert Waxman / Director, Supervisory Board
- Neil Koenig / Accountant
Current Share Structure
- Market Cap: $159,636 - 03/19/2018
- Authorized: 75,000,000 - 12/31/2014
- Issue and Outstanding: 53,211,864 - 12/31/2014
Daily Technical Chart for (OTC: OMRX)
Stay tuned for daily updates and more on (OTC: OMRX)
More to come on (OTC: OMRX)
Do your DD and if you choose, be ready to go!
The Research: All source information contained in this email is from the public sources mentioned below.
Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in OMRX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of OMRX and does not buy, sell, or trade any shares of OMRX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/